European Psychiatry: Volume 15 - Congress of the Association of European Psychiatrists

European Psychiatry

Only show content I have access to (976)

Over 3 years (976)

View selected items
Save to my bookmarks
Export citations
Download PDF (zip)
Save to Kindle
Save to Dropbox
Save to Google Drive
Save content to
To save this undefined to your undefined account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your undefined account. Find out more about saving content to .

To save this article to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Please be advised that item(s) you selected are not available.
You are about to save
European Psychiatry
ISSN: 0924-9338

EISSN: 1778-3585

URL: /core/journals/european-psychiatry
Your Kindle email address

Please provide your Kindle email.

@free.kindle.com @kindle.com (service fees apply)

By using this service, you agree that you will only keep content for personal use, and will not openly distribute them via Dropbox, Google Drive or other file sharing services

European Psychiatry

Refine listing

Actions for selected content:

Congress of the Association of European Psychiatrists

Posters, Monday, 30 October 2000

Symposia

P02.317 Olanzapine versus risperidone: A prospective comparison of clinical and economic outcomes in schizophrenia

P02.318 Global index of safety (GIS): A new instrument to assess drug safety: Application to a prospective pharmacoepidemiological study (EFESO)

P02.319 Antipsychotic treatment, adverse events and health-related quality of life

P02.320 Safety and effectiveness of olanzapine versus typical antipsychotic drugs in the treatment of inpatients with schizophrenia (Europa study)

P02.322 Effectiveness of biological and non biological treatments in schizophrenia

P02.321 Occurrence of CYP2D6 gene duplication in Hong Kong Chinese

P02.323 Autonomic disturbance in malignant catatonia

P02.324 Diagnosing psychiatric comorbidity in a drug-addiction unit

P02.325 Residential care in Andalusia and London: A comparison

P02.326 Standardised description of psychiatric care. The need to place every service in its specific context

P02.327 The influence of the computerized management system in the philosophy of the department of mental health of North East Italy

P02.328 The big five inventory: The French version

P02.329 Atypical versus conventional antipsychotic medication: Impact on subjective quality of life of patients with schizophrenia or related disorders

P02.330 Cost of a manic episode in bipolar disorder: A French study

P02.331 Medication management of a manic episode in bipolar disorder: A French study

P02.332 Schizotypy and hypomania as correlates of creative achievement

P02.333 Switching to amisulpride: Findings from a retrospective questionnaire

P02.334 The effect of amisulpride on affective and social negative syndromes in schizophrenia

P02.335 Pattern of prescription of antipsychotic drugs in psychiatric departments

P02.336 Assessing the impact of delivering information to schiizophrenic patients: The soleduc program

European Psychiatry

Refine listing

Actions for selected content:

Save Search

Congress of the Association of European Psychiatrists

Posters, Monday, 30 October 2000

Symposia